Search by Drug Name or NDC
NDC 63868-0934-10 Magnesium Citrate 1.745 g/29.6mL Details
Magnesium Citrate 1.745 g/29.6mL
Magnesium Citrate is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by QUALITY CHOICE (Chain Drug Marketing Association). The primary component is MAGNESIUM CITRATE.
MedlinePlus Drug Summary
Magnesium citrate is used to treat occasional constipation on a short-term basis. Magnesium citrate is in a class of medications called saline laxatives. It works by causing water to be retained with the stool. This increases the number of bowel movements and softens the stool so it is easier to pass.
Related Packages: 63868-0934-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Magnesium Citrate
Product Information
NDC | 63868-0934 |
---|---|
Product ID | 63868-934_4483878c-425a-41db-ae2f-96b18ddc2e9a |
Associated GPIs | 46100020102000 |
GCN Sequence Number | 003025 |
GCN Sequence Number Description | magnesium citrate SOLUTION ORAL |
HIC3 | D6S |
HIC3 Description | LAXATIVES AND CATHARTICS |
GCN | 09240 |
HICL Sequence Number | 001328 |
HICL Sequence Number Description | MAGNESIUM CITRATE |
Brand/Generic | Generic |
Proprietary Name | Magnesium Citrate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Magnesium citrate |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | ORAL |
Active Ingredient Strength | 1.745 |
Active Ingredient Units | g/29.6mL |
Substance Name | MAGNESIUM CITRATE |
Labeler Name | QUALITY CHOICE (Chain Drug Marketing Association) |
Pharmaceutical Class | Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part334 |
Listing Certified Through | n/a |
Package
Package Images

NDC 63868-0934-10 (63868093410)
NDC Package Code | 63868-934-10 |
---|---|
Billing NDC | 63868093410 |
Package | 296 mL in 1 BOTTLE, GLASS (63868-934-10) |
Marketing Start Date | 2014-06-30 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.00537 |
Pricing Unit | ML |
Effective Date | 2022-09-21 |
NDC Description | QC MAGNESIUM CITRATE SOLUTION |
Pharmacy Type Indicator | C/I |
OTC | Y |
Explanation Code | 4, 5 |
Classification for Rate Setting | G |
As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL d10b6d8e-f469-4bf2-8ab0-ff018618b5af Details
Uses
Warnings
Ask a doctor before use if you have
- kidney disease
- a magnesium restricted diet
- a sodium restricted diet
- stomach pain, nausea or vomiting
- noticed a sudden change in bowel habits that lasts more than 1 week
Directions
adults and children 12 years of age and older | 1/2 to 1 bottle (10 fl. oz.). Drink a full 8 oz. glass of liquid with each dose. The dose may be taken as a single daily dose or in divided doses. |
children 6 to 11 years of age | 1/3 to 1/2 bottle with a full 8 oz. glass of liquid |
children under 6 years of age | consult a doctor |
Other information
Inactive ingredients
Principal Display Panel
INGREDIENTS AND APPEARANCE
MAGNESIUM CITRATE
magnesium citrate liquid |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Labeler - QUALITY CHOICE (Chain Drug Marketing Association) (011920774) |
Revised: 11/2022
Document Id: 4483878c-425a-41db-ae2f-96b18ddc2e9a
Set id: d10b6d8e-f469-4bf2-8ab0-ff018618b5af
Version: 4
Effective Time: 20221104